OpenVSafe by OpenVAERS
Search V-safe

ZBL-14673-19212

3 vaccinations 5 coded responses 25 check-ins 5 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
483 / MI
Registered
2021-01-12
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-09
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-12
    Registered in v-safe
  3. 2021-01-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  4. 2021-01-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-16
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-23
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-01-29
    Dose 2 — Pfizer-BioNTech
  10. 2021-01-29
    Health check-in — day 0, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  11. 2021-01-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  12. 2021-01-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Large swollen axillary lymph node (right arm-same as injection site)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Swollen axillary lymph node on side of injection
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-02-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Swelling
    Free text: Edema/swollen lymph nodes in right axilla, up right side of neck and extending around right upper torso
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Swelling · None
    Adult check-in
  16. 2021-02-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-02-05
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-12
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-02-19
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-26
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-05
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-12
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-30
    Survey response — 3 months, dose 2
    MedDRA: Breast swelling, Injection site swelling, Localised oedema, Lymphadenopathy, Oedema peripheral, Peripheral swelling, Swelling — Feeling: Good
    Free text: I continue to have on & off swelling of a lymph node in my right lateral breast. My second injection was in my right deltoid and I experienced extensive swelling in my right axilla, shoulder, breast, & clavicle, for about 5 days afterwards.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-07-30
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-11-12
    Dose 3 — Pfizer-BioNTech
  26. 2022-01-29
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2022-02-13
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  28. 2022-05-13
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  29. 2022-11-12
    Survey response — 12 months, dose 3
    MedDRA: Insomnia, Migraine — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Migraines every 3-4 weeks, insomnia nightly. Both require prescription medications.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-11-12
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  31. 2022-11-14

Vaccinations

DoseDateManufacturerCo-administered
12021-01-09Pfizer-BioNTech
22021-01-29Pfizer-BioNTech
32021-11-12Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-11-12 Unsuccessful

Free text

Release 3 — days 1–6 daily, dose 2

2021-01-31

Systemic reaction (other): Large swollen axillary lymph node (right arm-same as injection site)

2021-02-01

Systemic reaction (other): Swollen axillary lymph node on side of injection

2021-02-02

Systemic reaction (other): Edema/swollen lymph nodes in right axilla, up right side of neck and extending around right upper torso

Release 8 — 3 months, dose 2

2021-04-30

Symptoms: I continue to have on & off swelling of a lymph node in my right lateral breast. My second injection was in my right deltoid and I experienced extensive swelling in my right axilla, shoulder, breast, & clavicle, for about 5 days afterwards.

Release 12 — 12 months, dose 3

2022-11-12

Symptoms: Migraines every 3-4 weeks, insomnia nightly. Both require prescription medications.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBreast swelling ✓ ✓ ✓
SDInjection site swelling ○ ✓ ○
SDInsomnia · · ✓
SDLocalised oedema ○ ✓ ○
SDLymphadenopathy ✓ ✓ ✓
SDMigraine · · ✓
SDOedema peripheral ✓ · ✓
SDPeripheral swelling ○ ✓ ○
SDSwelling ✓ · ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release